Punctate inner choroidopathy (PIC) and multifocal choroidopathy (MFC) with panuveitis are different conditions and not part of a spectrum of the same disease. Considering them as separate entities is important.
In a placebo-controlled phase II study of patients with severe non-infectious uveitis involving the posterior segment, subcutaneous sarilumab demonstrated promising therapeutic activity.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
